Mechanisms of Neuroprotection by Quercetin: Counteracting Oxidative Stress and More

Lucio G. Costa1,2, Jacqueline M. Garrick1, Pamela J. Roqué1, Claudia Pellacani2
1Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA 98105, USA
2Department of Neuroscience, University of Parma Medical School, 43100 Parma, Italy

Tóm tắt

Increasing interest has recently focused on determining whether several natural compounds, collectively referred to as nutraceuticals, may exert neuroprotective actions in the developing, adult, and aging nervous system. Quercetin, a polyphenol widely present in nature, has received the most attention in this regard. Several studies in vitro, in experimental animals and in humans, have provided supportive evidence for neuroprotective effects of quercetin, either against neurotoxic chemicals or in various models of neuronal injury and neurodegenerative diseases. The exact mechanisms of such protective effects remain elusive, though many hypotheses have been formulated. In addition to a possible direct antioxidant effect, quercetin may also act by stimulating cellular defenses against oxidative stress. Two such pathways include the induction of Nrf2‐ARE and induction of the antioxidant/anti‐inflammatory enzyme paraoxonase 2 (PON2). In addition, quercetin has been shown to activate sirtuins (SIRT1), to induce autophagy, and to act as a phytoestrogen, all mechanisms by which quercetin may provide its neuroprotection.

Từ khóa


Tài liệu tham khảo

USDA (United States Department of Agriculture), 2003, USDA Database for the Flavonoid Content of Selected Foods

10.1089/ars.2012.4581

10.1039/c4fo01178c

10.3390/nu7042345

10.1016/j.fct.2007.05.015

10.1016/j.jnutbio.2014.10.008

10.1093/jn/135.7.1718

10.1093/ajcn/81.1.230S

10.1093/jn/128.3.593

10.1093/ajcn/79.5.727

10.3109/10715760903407293

Kelly G. S., 2011, Quercetin. Monograph, Alternative Medicine Review, 16, 172

10.1016/s0891-5849(01)00522-6

10.1080/10715760600794287

10.1055/s-0030-1250735

10.1016/j.jnutbio.2010.02.008

10.1016/j.abb.2014.03.003

10.1016/j.jnutbio.2011.08.007

10.1080/10715760310001615998

10.2478/s11658-010-0006-4

10.1016/j.freeradbiomed.2011.06.017

10.1007/s12263-011-0255-5

10.1016/j.phrs.2009.08.006

10.1016/j.bcp.2011.08.010

10.2174/1874609810801030169

10.1111/j.2042-7158.2010.01225.x

10.1039/c4fo00817k

10.1016/j.ejphar.2008.03.008

10.1517/14740330903026944

10.1016/j.jep.2012.07.005

10.1016/j.bcp.2004.09.018

10.1016/j.abb.2008.03.011

10.1016/j.freeradbiomed.2010.05.020

10.1007/s11064-013-1085-1

10.1007/s12031-014-0400-x

10.1007/s00709-015-0821-6

10.1016/j.jnutbio.2008.03.002

10.1007/s00210-008-0301-z

10.1007/s12640-011-9253-z

10.1007/s00204-011-0652-y

10.1155/2012/928643

10.1007/s11356-014-3885-5

10.1016/j.fct.2015.05.003

10.1093/ajcn/81.1.317S

10.1155/2012/914273

10.1155/2013/891748

10.1016/j.physbeh.2014.09.008

10.1007/s11064-014-1457-1

10.5935/0004-2749.20150026

10.1016/j.neuropharm.2015.01.027

10.1016/j.pnpbp.2012.08.018

10.1007/s11064-015-1542-0

10.1038/nature05292

10.1017/s0963548305007352

10.1155/2013/963520

10.1007/s10495-007-0756-2

10.1089/ars.2008.2236

10.1007/s12263-009-0136-3

10.1016/j.fct.2014.07.038

10.1093/ajcn/81.1.268S

10.1016/j.mam.2010.09.006

10.1016/j.abb.2008.01.028

10.1111/j.1365-2125.2012.04272.x

10.1089/ars.2009.3074

10.1016/j.taap.2007.02.015

10.1074/jbc.m414635200

10.1021/jf304768p

10.1016/j.bbadis.2013.12.011

10.1007/s11064-011-0417-2

10.1016/j.cbi.2011.12.005

10.1016/j.tins.2006.09.001

10.1194/jlr.M400511-JLR200

10.1074/jbc.m605379200

10.1074/jbc.m105660200

10.1016/j.freeradbiomed.2008.03.023

10.1016/j.taap.2011.02.014

10.1006/geno.1996.0225

10.1016/j.freeradbiomed.2013.01.019

10.1089/ars.2010.3430

10.1016/j.neuro.2013.08.011

10.1161/CIRCULATIONAHA.106.681700

10.1074/jbc.m110.118604

10.1016/j.jnutbio.2009.01.014

10.1161/01.ATV.0000059385.95664.4D

Costa L. G., 2015, Nutraceuticals: Efficacy, Safety, and Toxicity

10.3390/ijms10094168

10.1080/01635580902825571

10.1080/01635580903441196

10.1002/mnfr.200800239

10.1016/j.ceb.2010.10.001

10.1016/s1734-1140(12)71257-4

10.1016/j.redox.2013.12.013

10.1016/j.neuroscience.2009.08.014

10.1038/nature04723

10.4103/1673-5374.135328

10.1002/mnfr.201400014

10.1016/j.ddtec.2012.08.003

10.1016/j.virusres.2015.05.015

10.2174/1871527313666141130224206

10.1097/yco.0000000000000140

10.1007/s12640-012-9328-5

10.1016/j.ejphar.2005.08.005

10.1002/jnr.21503

10.1016/j.brainresbull.2007.01.016

10.1038/sj.bjc.6690479

10.1002/mnfr.200500036

10.1002/jcp.22917

10.1016/j.bbagen.2009.11.013

10.1016/j.tem.2011.08.002

10.1016/j.numecd.2009.05.015